5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide

C96H111N23O6 — CID 161088509

IUPAC5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide
SMILESCC(C)c1ccc(NC(=O)c2cccnc2)c(N2CCN(C(=O)Nc3ccccc3)CC2)c1.Cc1ccc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)cn1.Cc1cncc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)c1.Cc1oncc1C(=O)Nc1ccc(C(C)C)cc1N1CCN(c2cnccn2)CC1
InChIInChI=1S/C26H29N5O2.2C24H28N6O.C22H26N6O2/c1-19(2)20-10-11-23(29-25(32)21-7-6-12-27-18-21)24(17-20)30-13-15-31(16-14-30)26(33)28-22-8-4-3-5-9-22;1-17(2)19-4-5-21(28-24(31)20-12-18(3)14-26-15-20)22(13-19)29-8-10-30(11-9-29)23-16-25-6-7-27-23;1-17(2)19-6-7-21(28-24(31)20-5-4-18(3)27-15-20)22(14-19)29-10-12-30(13-11-29)23-16-25-8-9-26-23;1-15(2)17-4-5-19(26-22(29)18-13-25-30-16(18)3)20(12-17)27-8-10-28(11-9-27)21-14-23-6-7-24-21/h3-12,17-19H,13-16H2,1-2H3,(H,28,33)(H,29,32);4-7,12-17H,8-11H2,1-3H3,(H,28,31);4-9,14-17H,10-13H2,1-3H3,(H,28,31);4-7,12-15H,8-11H2,1-3H3,(H,26,29)
InChIKeyUGVUXDVHDLJHJG-UHFFFAOYSA-N
MW1683.10 g/mol
LogP16.05
Rot. Bonds20

About 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide

5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide (PubChem CID 161088509) has the molecular formula C96H111N23O6 and a molecular weight of 1683.10 g/mol. Its IUPAC name is 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide.

Molecular Properties

Compound Name5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide
PubChem CID161088509
Molecular FormulaC96H111N23O6
Molecular Weight1683.10 g/mol
Exact Mass1681.91
IUPAC Name5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide
SMILESCC(C)c1ccc(NC(=O)c2cccnc2)c(N2CCN(C(=O)Nc3ccccc3)CC2)c1.Cc1ccc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)cn1.Cc1cncc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)c1.Cc1oncc1C(=O)Nc1ccc(C(C)C)cc1N1CCN(c2cnccn2)CC1
InChIInChI=1S/C26H29N5O2.2C24H28N6O.C22H26N6O2/c1-19(2)20-10-11-23(29-25(32)21-7-6-12-27-18-21)24(17-20)30-13-15-31(16-14-30)26(33)28-22-8-4-3-5-9-22;1-17(2)19-4-5-21(28-24(31)20-12-18(3)14-26-15-20)22(13-19)29-8-10-30(11-9-29)23-16-25-6-7-27-23;1-17(2)19-6-7-21(28-24(31)20-5-4-18(3)27-15-20)22(14-19)29-10-12-30(13-11-29)23-16-25-8-9-26-23;1-15(2)17-4-5-19(26-22(29)18-13-25-30-16(18)3)20(12-17)27-8-10-28(11-9-27)21-14-23-6-7-24-21/h3-12,17-19H,13-16H2,1-2H3,(H,28,33)(H,29,32);4-7,12-17H,8-11H2,1-3H3,(H,28,31);4-9,14-17H,10-13H2,1-3H3,(H,28,31);4-7,12-15H,8-11H2,1-3H3,(H,26,29)
InChIKeyUGVUXDVHDLJHJG-UHFFFAOYSA-N
XLogP16.05
TPSA313.46 Ų
H-Bond Donors5
H-Bond Acceptors23
Rotatable Bonds20
Heavy Atoms125
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001683.10
LogP ≤ 516.05
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1023

Analyze 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide?
The IUPAC name of 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide (CID 161088509) is 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide.
What is the SMILES notation for 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide?
The canonical SMILES for 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide is CC(C)c1ccc(NC(=O)c2cccnc2)c(N2CCN(C(=O)Nc3ccccc3)CC2)c1.Cc1ccc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)cn1.Cc1cncc(C(=O)Nc2ccc(C(C)C)cc2N2CCN(c3cnccn3)CC2)c1.Cc1oncc1C(=O)Nc1ccc(C(C)C)cc1N1CCN(c2cnccn2)CC1.
What is the InChIKey of 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide?
The InChIKey is UGVUXDVHDLJHJG-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29N5O2.2C24H28N6O.C22H26N6O2/c1-19(2)20-10-11-23(29-25(32)21-7-6-12-27-18-21)24(17-20)30-13-15-31(16-14-30)26(33)28-22-8-4-3-5-9-22;1-17(2)19-4-5-21(28-24(31)20-12-18(3)14-26-15-20)22(13-19)29-8-10-30(11-9-29)23-16-25-6-7-27-23;1-17(2)19-6-7-21(28-24(31)20-5-4-18(3)27-15-20)22(14-19)29-10-12-30(13-11-29)23-16-25-8-9-26-23;1-15(2)17-4-5-19(26-22(29)18-13-25-30-16(18)3)20(12-17)27-8-10-28(11-9-27)21-14-23-6-7-24-21/h3-12,17-19H,13-16H2,1-2H3,(H,28,33)(H,29,32);4-7,12-17H,8-11H2,1-3H3,(H,28,31);4-9,14-17H,10-13H2,1-3H3,(H,28,31);4-7,12-15H,8-11H2,1-3H3,(H,26,29).
What are the key properties of 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide?
5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide has a molecular weight of 1683.10 g/mol, XLogP of 16.05, 20 rotatable bonds, 5 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]-1,2-oxazole-4-carboxamide;5-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;6-methyl-N-[4-propan-2-yl-2-(4-pyrazin-2-ylpiperazin-1-yl)phenyl]pyridine-3-carboxamide;N-phenyl-4-[5-propan-2-yl-2-(pyridine-3-carbonylamino)phenyl]piperazine-1-carboxamide is sourced from PubChem (CID 161088509), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).